ipilimumab,nivolumab
bms
['check,mate,214']
hrqol is associated with outcomes in patients with advanced #kidneycancer #checkmate-214 trial #asco22 
Medical oncologist. Lung and genitourinary cancer.
#lcsm #pcsm #kcsm